The implication of these abnormalities in the rewarding properties exhibited by L-Dopa in the PD model suggests that therapeutic approaches targeting excessive D1R-mediated transmission may be beneficial for the treatment of DDS. This evidence concerns the gene DRD1 and Parkinson disease.